Organisation paid for research Program year 2025 Source: CMS Open Payments

US Onc Research LLC

Neither a doctor nor a teaching hospital

Research payments

$8,979,294

201 payments

Through program year 2025, US Onc Research LLC is reported as receiving $8,979,294 in research payments, across 201 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$1,209,131	13
2024	Research	$782,867	1
2023	Research	$2,216,149	43
2021	Research	$220,181	1
2020	Research	$1,579,524	66
2019	Research	$2,971,442	77

Breakdown

Who paid Research payments · program years 2019–2025

Amgen Inc. $8,979,294 201 payments

Studies the money was for Research payments · program years 2019–2025

Prospective Observational Study of Onpro vs SOC $2,762,026 70 payments
Molecularly-Informed Lung Cancer Treatment in a Community Cancer Network: A Pragmatic Consortium $2,568,781 4 payments
Prospective Observational Study of Onpro vs SOC. $1,052,430 37 payments
AMG 510 Ph1b Master Protocol 20190135 $336,566 5 payments
P3 2L NSCLC Mono Comparator $329,870 9 payments
BEMA Ph2 Basket Study $277,176 3 payments
Select $231,968 9 payments
A Phase 1b, Protocol Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Sotorasib Monotherapy and in Combination With Other Anti-cancer Therapies in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) $223,876 4 payments
AMG 510_P1/2 Monotherapy NSCLC/CRC/Tumor Agnostic_20170543. $209,416 7 payments
AMG 510_P1/2 Monotherapy NSCLC/CRC/Tumor Agnostic_20170543 $173,135 6 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.